Literature DB >> 9415101

Telomeres, telomerase, and aging: origin of the theory.

A M Olovnikov1.   

Abstract

In 1971 I published a theory in which I first formulated the DNA end replication problem and explained how it could be solved. The solution to this problem also provided an explanation for the Hayflick Limit, which underpins the discovery of in vitro and in vivo cell senescence. I proposed that the length of telomeric DNA, located at the ends of chromosomes consists of repeated sequences, which play a buffer role and should diminish in dividing normal somatic cells at each cell doubling. I also proposed that the loss of sequences containing important information that could occur after buffer loss could cause the onset of cellular senescence. I also suggested that for germline cells and for the cells of vegetatively propagated organisms and immortal cell populations like most cancer cell lines, an enzyme might be activated that would prevent the diminution of DNA termini at each cell division, thus protecting the information containing part of the genome. In the last few years, most of my suggestions have been authenticated by laboratory evidence. the DNA sequences that shorten in dividing normal cells are telomeres and the enzyme that maintains telomere length constant in immortal cell populations is telomerase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9415101     DOI: 10.1016/0531-5565(96)00005-8

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  99 in total

1.  Identification of two human nuclear proteins that recognise the cytosine-rich strand of human telomeres in vitro.

Authors:  L Lacroix; H Liénard; E Labourier; M Djavaheri-Mergny; J Lacoste; H Leffers; J Tazi; C Hélène; J L Mergny
Journal:  Nucleic Acids Res       Date:  2000-04-01       Impact factor: 16.971

2.  An alternative lifestyle for immortalized oral keratinocytes.

Authors:  R R Reddel
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  A genome-wide screen for Saccharomyces cerevisiae deletion mutants that affect telomere length.

Authors:  Syed H Askree; Tal Yehuda; Sarit Smolikov; Raya Gurevich; Joshua Hawk; Carrie Coker; Anat Krauskopf; Martin Kupiec; Michael J McEachern
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

4.  Changes of chromosomes and cell cycle (endoreduplication, somatic crossing-over, and robertsonian fusions) in hepatocytes of senescence accelerated SAMR1 mice.

Authors:  I V Uryvaeva; G V Delone; T L Marshak; M L Semenova; S T Zakhidov
Journal:  Dokl Biol Sci       Date:  2004 Mar-Apr

5.  Homologous recombination in human telomerase-positive and ALT cells occurs with the same frequency.

Authors:  Oliver E Bechter; Ying Zou; Jerry W Shay; Woodring E Wright
Journal:  EMBO Rep       Date:  2003-11-14       Impact factor: 8.807

6.  Global heterochromatin loss: a unifying theory of aging?

Authors:  Amy Tsurumi; Willis X Li
Journal:  Epigenetics       Date:  2012-07-01       Impact factor: 4.528

Review 7.  Ovarian aging and premature ovarian failure.

Authors:  Yavuz Emre Sükür; Içten Balık Kıvançlı; Batuhan Ozmen
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

8.  Human AP-endonuclease (Ape1) activity on telomeric G4 structures is modulated by acetylatable lysine residues in the N-terminal sequence.

Authors:  Silvia Burra; Daniela Marasco; Matilde Clarissa Malfatti; Giulia Antoniali; Antonella Virgilio; Veronica Esposito; Bruce Demple; Aldo Galeone; Gianluca Tell
Journal:  DNA Repair (Amst)       Date:  2018-11-22

9.  Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study.

Authors:  J E Verhoeven; D Révész; E S Epel; J Lin; O M Wolkowitz; B W J H Penninx
Journal:  Mol Psychiatry       Date:  2013-11-12       Impact factor: 15.992

10.  Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease.

Authors:  Ramin Farzaneh-Far; Jue Lin; Elissa S Epel; William S Harris; Elizabeth H Blackburn; Mary A Whooley
Journal:  JAMA       Date:  2010-01-20       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.